Published in J Surg Oncol on June 04, 2012
A proposal for the timing of management of patients with melanoma presenting during pregnancy. J Surg Oncol (2012) 1.40
Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med (2010) 8.10
Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study. J Clin Oncol (2013) 4.28
Pediatric Outcome after Maternal Cancer Diagnosed during Pregnancy. N Engl J Med (2015) 3.37
Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study. Lancet Oncol (2012) 2.83
Treatment of breast cancer during pregnancy: an observational study. Lancet Oncol (2012) 2.38
Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J Clin Oncol (2009) 2.14
14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma. Proc Natl Acad Sci U S A (2012) 1.51
L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluation. J Natl Cancer Inst (2013) 1.40
Immunohistochemical determination of hormone receptors in uterine adenosarcomas. Gynecol Oncol (2003) 1.39
The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor. Am J Surg Pathol (2012) 1.09
Is chemotherapy during the first trimester of pregnancy really safe? Int J Cancer (2012) 1.09
Optimal staging of lymphoma during pregnancy is crucial. Womens Health (Lond Engl) (2015) 1.07
High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinoma. Gynecol Oncol (2012) 1.06
Gynaecologic cancer complicating pregnancy: an overview. Best Pract Res Clin Obstet Gynaecol (2009) 0.99
Gynecologic cancers in pregnancy: guidelines of a second international consensus meeting. Int J Gynecol Cancer (2014) 0.98
Wilms' Tumor Gene 1 (WT1)--loaded dendritic cell immunotherapy in patients with uterine tumors: a phase I/II clinical trial. Anticancer Res (2013) 0.96
Neoadjuvant chemotherapy is the better treatment option in some patients with stage IIIc to IV ovarian cancer. J Clin Oncol (2011) 0.95
Immunological response after therapeutic vaccination with WT1 mRNA-loaded dendritic cells in end-stage endometrial carcinoma. Anticancer Res (2010) 0.95
Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors. Breast Cancer Res Treat (2008) 0.94
The "Leuven" dose-dense paclitaxel/carboplatin regimen in patients with recurrent ovarian cancer. Gynecol Oncol (2007) 0.90
Immunological response after WT1 mRNA-loaded dendritic cell immunotherapy in ovarian carcinoma and carcinosarcoma. Anticancer Res (2013) 0.89
Primary surgery or neoadjuvant chemotherapy in ovarian cancer: what is the value of comparing apples with oranges? Gynecol Oncol (2012) 0.89
Management of gynecological cancers during pregnancy. Curr Oncol Rep (2014) 0.88
Cancer in pregnancy: a survey of current clinical practice. Eur J Obstet Gynecol Reprod Biol (2012) 0.88
Treatment of high-risk gestational trophoblastic neoplasia with weekly high-dose methotrexate-etoposide. Gynecol Oncol (2012) 0.87
Evolution in endometrial cancer: evidence from an immunohistochemical study. Int J Gynecol Cancer (2011) 0.87
Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer. Eur J Cancer (2011) 0.86
The role of adjuvant chemotherapy in surgical stages I-II serous and clear cell carcinomas and carcinosarcoma of the endometrium: a collaborative study. Int J Gynecol Cancer (2011) 0.85
Leuven dose-dense paclitaxel/carboplatin regimen in patients with primary advanced or recurrent endometrial carcinoma. Int J Gynecol Cancer (2009) 0.84
Physiologic variations of serum tumor markers in gynecological malignancies during pregnancy: a systematic review. BMC Med (2012) 0.84
Prophylactic mastectomy in familial breast carcinoma. What do the pathologic findings learn us? Breast Cancer Res Treat (2007) 0.84
Pharmacokinetics of chemotherapeutic agents in pregnancy: a preclinical and clinical study. Acta Obstet Gynecol Scand (2010) 0.83
Weekly paclitaxel/carboplatin in the treatment of locally advanced, recurrent, or metastatic vulvar cancer. Int J Gynecol Cancer (2012) 0.82
Psychologic, relational, and sexual functioning in women after surgical treatment of vulvar malignancy: a prospective controlled study. Int J Gynecol Cancer (2014) 0.81
The use of lymph vessel markers to predict endometrial cancer outcome. Int J Gynecol Cancer (2010) 0.81
Being Pregnant and Diagnosed with Breast Cancer. Breast Care (Basel) (2012) 0.80
Substantial variation in transplacental transfer of chemotherapeutic agents in a mouse model. Reprod Sci (2010) 0.80
Sexual functioning in women after surgical treatment for endometrial cancer: a prospective controlled study. J Sex Med (2014) 0.80
Transplacental transfer of paclitaxel, docetaxel, carboplatin, and trastuzumab in a baboon model. Int J Gynecol Cancer (2010) 0.80
Vinblastine and doxorubicin administration to pregnant mice affects brain development and behaviour in the offspring. Neurotoxicology (2009) 0.80
Chemotherapy during pregnancy. Curr Opin Oncol (2012) 0.80
Microsatellite instable and microsatellite stable primary endometrial carcinoma cells and their subcutaneous and orthotopic xenografts recapitulate the characteristics of the corresponding primary tumor. Int J Gynecol Cancer (2015) 0.79
Wilms tumor gene 1 (WT1) is a prognostic marker in high-grade uterine sarcoma. Int J Gynecol Cancer (2011) 0.79
Epithelial ovarian cancer: rationale for changing the one-fits-all standard treatment regimen to subtype-specific treatment. Int J Gynecol Cancer (2014) 0.79
Wilms' tumor gene 1 (WT1) in endometrial carcinoma. Gynecol Oncol (2008) 0.79
Weekly paclitaxel-carboplatin regimen in patients with primary advanced or recurrent endometrial carcinoma. Int J Gynecol Cancer (2012) 0.79
Lymphadenectomy in endometrial cancer. Lancet (2009) 0.79
Increased expression of placental growth factor in high-grade endometrial carcinoma. Oncol Rep (2012) 0.78
Cancer during pregnancy. Acta Obstet Gynecol Scand (2014) 0.78
Fetal outcome after prenatal exposure to chemotherapy and mechanisms of teratogenicity compared to alcohol and smoking. Expert Opin Drug Saf (2014) 0.78
Expression of ERCC1, p53, and class III β-tubulin do not reveal chemoresistance in endometrial cancer: results from an immunohistochemical study. Int J Gynecol Cancer (2011) 0.78
Myocardial function in children after fetal chemotherapy exposure. A tissue Doppler and myocardial deformation imaging study. Eur J Pediatr (2012) 0.78
Feasibility of ultrasound-guided percutaneous samplings in the pregnant baboon: a model for studies on transplacental transport. Reprod Sci (2008) 0.78
Genetic changes in nonepithelial ovarian cancer. Expert Rev Anticancer Ther (2013) 0.78
Screening for ovarian carcinoma: not quite there yet. Lancet Oncol (2009) 0.77
Effects of chemotherapy during pregnancy on the maternal and fetal heart. Prenat Diagn (2012) 0.77
Long-term sexual functioning in women after surgical treatment of cervical cancer stages IA to IB: a prospective controlled study. Int J Gynecol Cancer (2014) 0.77
Mutation profile and clinical outcome of mixed endometrioid-serous endometrial carcinomas are different from that of pure endometrioid or serous carcinomas. Virchows Arch (2015) 0.77
Chemotherapy during pregnancy: effect of anthracyclines on fetal and maternal cardiac function. Acta Obstet Gynecol Scand (2012) 0.77
Should we screen for endometrial cancer? Lancet Oncol (2010) 0.76
Fetal rat hearts do not display acute cardiotoxicity in response to maternal Doxorubicin treatment. J Pharmacol Exp Ther (2013) 0.76
Does paclitaxel-carboplatin chemotherapy in a dose-dense regimen enhance survival of BRCA-related ovarian cancer patients? Int J Gynecol Cancer (2009) 0.76
Incidence of positive peritoneal cytology in low-risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy. Gynecol Oncol (2002) 0.75
Use of chemotherapy during pregnancy in the treatment of ovarian malignancies. Eur J Obstet Gynecol Reprod Biol (2011) 0.75
Pediatric Outcome after Maternal Cancer Diagnosed during Pregnancy. N Engl J Med (2016) 0.75
Wilms' tumor gene 1 (WT1) overexpression in neurons in deep endometriosis: a pilot study. Fertil Steril (2008) 0.75
Reply to D. Crivellari et al. J Clin Oncol (2013) 0.75
What is the role of neoadjuvant chemotherapy in advanced endometrial cancer? Gynecol Oncol (2010) 0.75
The "Leuven" paclitaxel/carboplatin weekly regimen in patients with recurrent ovarian cancer, a retrospective study. Gynecol Oncol (2012) 0.75
Dendritic cell immunotherapy in uterine cancer. Hum Vaccin Immunother (2014) 0.75
Residual tumor after neoadjuvant chemotherapy and interval debulking surgery for advanced endometrial cancer. Gynecol Oncol (2009) 0.75
Cervical cancer in pregnant women: treat, wait or interrupt? Assessment of current clinical guidelines, innovations and controversies. Ther Adv Med Oncol (2013) 0.75
Bifunctional pathway of uterine carcinosarcomas. Hum Pathol (2003) 0.75
Effects of fetal exposure to maternal chemotherapy. Paediatr Drugs (2013) 0.75
Molecular profiling of platinum resistant ovarian cancer: use of the model in clinical practice. Int J Cancer (2006) 0.75
Tongue cancers during pregnancy: Case reports and review of literature. Head Neck (2011) 0.75
Fertility Preservation Is Safe for Serous Borderline Ovarian Tumors. Int J Gynecol Cancer (2016) 0.75
Kit gene in endometrial carcinoma: an immunohistochemical and mutational analysis. Int J Gynecol Cancer (2011) 0.75
Melanoma during pregnancy: a report of 60 pregnancies complicated by melanoma. Melanoma Res (2017) 0.75
EP-EMA regimen (etoposide and cisplatin with etoposide, methotrexate, and dactinomycin) in a series of 18 women with gestational trophoblastic neoplasia. Int J Gynecol Cancer (2012) 0.75
Neoadjuvant Weekly Paclitaxel-Carboplatin Is Effective in Stage I-II Cervical Cancer. Int J Gynecol Cancer (2017) 0.75
Uterine and quality of life changes in postmenopausal women with an asymptomatic tamoxifen-thickened endometrium randomized to continuation of tamoxifen or switching to anastrozole. Menopause (2011) 0.75
Interrogating open issues in cancer medicine with patient-derived xenografts. Nat Rev Cancer (2017) 0.75
Cancer in pregnancy: safety and efficacy of systemic therapies. Curr Opin Oncol (2017) 0.75